Bird Flu - Archives
will start manufacturing Tamiflu in three to five months. Roche, which has
production rights for the drug, and Gilead Sciences, which developed it, do
not hold an Indonesian patent. It is likely that manufacture will be carried
out by two state-owned drugs companies, PT Kimia Farma and PT Indofarma,
using raw materials sourced from China, India and South Korea.
Intellectual Property Office is likely to authorize
local production of Tamiflu, in violation of the rights of Roche and
executive Franz B. Humer has told the
York Times that it will announce in early December which companies
will be allowed to start their own Tamiflu production.
Koreans Make Tamiflu; Taiwanese Find New Shikimic Acid Source
sources are reporting that a local firm, Hanmi Pharmaceutical, has succeeded
producing its own version of Tamiflu. Earlier, 16 Korean drugs companies
had responded to a call from the Korean Food and Drug Administration to
produce generic Tamiflu samples by December 5th. So far, Hanmi is
the only company to have reported success, and it is now in negotiation with
Roche about obtaining a licence to begin full production.
Post is reporting that Taiwanese scientists have
succeeded in extracting shikimic acid – the base material of Tamiflu –
from three local plants. Until now, the main natural source of the acid has
star anise plant, and this is in increasingly short supply, due to
soaring demand from Tamiflu’s manufacturer Roche.
News Round-Up (Most of
The Thai government has
confirmed its first
bird flu fatality in a year. It is the country’s 13th bird
flu death. The official WHO announcement is
Australia, three pigeons – part of a shipment of 102 racing and show
pigeons from Canada – were found to have bird flu antibodies.
quarantine authorities had reportedly certified the infected birds as
has reportedly discovered H5N1-infected birds that were being smuggled in
A lengthy report in the
Washington Post says Indonesia has been engaged in a two-year cover-up
of its growing bird flu problem.
has an excellent report on the global fight against the virus.
The Taiwanese Department
of Health has
to Roche requesting negotiations on the generic production of Tamiflu.
Meanwhile, Thailand is apparently
with its own production, without consulting Roche.
Generic Production Urged
Holdings is reportedly
under pressure to allow production of generic versions of its anti-flu
drug Tamiflu. The reports say the company believes the drug is so complex
that generic maker would struggle to produce significant quantities. This is
contradicted by Taiwanese authorities, who believe they could begin
manufacture within months of receiving permission.